HLA-B*57:01 typing in a Malaysian cohort: implications of abacavir hypersensitivity in people living with HIV
出版年份 2023 全文链接
标题
HLA-B*57:01 typing in a Malaysian cohort: implications of abacavir hypersensitivity in people living with HIV
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume -, Issue -, Pages -
出版商
Future Medicine Ltd
发表日期
2023-09-28
DOI
10.2217/pgs-2023-0136
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost‐Effectiveness of Preemptive Pharmacogenetic Testing
- (2020) Yitian Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study
- (2019) Karam Mounzer et al. AIDS Research and Therapy
- Incidental pharmacogenetics findings in an HLA ‐related research: Considerations for primary prevention
- (2019) Mohammed Faizal Bakhtiar et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Low frequency of hypersensitivity reactions to abacavir in HIV infected patients in a referral center in Bahia, Brazil
- (2019) Raphael Gusmão Barreto et al. Brazilian Journal of Infectious Diseases
- Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet–collagen interactions
- (2018) Jane A. O’Halloran et al. AIDS
- Pharmacogenetics of abacavir hypersensitivity: A systematic review and meta-analysis of the association with HLA-B*57:01
- (2015) Bernardo Sousa-Pinto et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription
- (2015) Ritika Kapoor et al. Pharmacogenetics and Genomics
- Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations
- (2014) Nisha Esakimuthu Pillai et al. HUMAN MOLECULAR GENETICS
- Abacavir Pharmacogenetics - From Initial Reports to Standard of Care
- (2013) Michael A. Martin et al. PHARMACOTHERAPY
- Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine
- (2013) YongLi Guo et al. Science China-Life Sciences
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
- (2012) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods
- (2012) Laura Stocchi et al. CURRENT GENOMICS
- Antiretroviral drugs: Critical issues and recent advances
- (2012) Mira Desai et al. INDIAN JOURNAL OF PHARMACOLOGY
- Hypersensitivity reactions to HIV therapy
- (2010) Mas Chaponda et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART
- (2010) Paula Munderi et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients
- (2008) Michael Saag et al. CLINICAL INFECTIOUS DISEASES
- Should HLA‐B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
- (2008) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events
- (2007) Sara Hughes et al. PHARMACEUTICAL STATISTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started